MTPConnect Webinars


Welcome to the MTPConnect Webinar page.

View all our on-demand webinars below.


Show Me The Money: Preparing Successful Commercialisation Funding Applications. Listen to Our Webinar!

  • 18 November 2020

We’re patching you into our November 2020 Seminar Series webinar about how to craft a successful commercialisation funding application. Hear valuable tips from communications specialist and grant writer Rebecca Colless from gemaker, experienced grant assessor Dr Andy Gearing from BioComm Squared and Associate Professor Kevin Pfleger from UWA who shares his academic and commercial experience, highlighting key differences between research and commercialisation applications. MTPConnect’s Dr Dan Grant brings insights from his own research career and administering MTPConnect’s multiple translation funding programs. They explore the steps to developing a well-executed application, share their experiences and reveal why it is so important to get the story right. The session was led by MTPConnect’s Director of Stakeholder Engagement for WA Dr Tracey Wilkinson. This episode will be of interest to researchers, research offices, start-ups & SMEs.


REDI Information Session: Call for Proposals for Skills Gap Training Programs

  • 19 November 2020

In delivering the REDI program, MTPConnect is partnering with research, training and industry organisations to deploy an integrated three-pillar plan driving skills and workforce development for the MTP sector nationally.

Our REDI initiative has undertaken a medtech & pharma Industry skills gap analysis and identified several critical skills gaps that inhibit the industry maximising the impact on healthcare in Australia. The call for proposals for REDI Pillar 2 Round One for ‘urgent skills gap training courses/programs’ close at 17.00hrs (AEDT) on Tuesday, 15 December 2020.


Why Australia is the Destination of Choice for International Medical Device Clinical Trials

  • 06 October 2020

To mark our involvement in the Virtual MedTech Conference 2020 in Toronto, we hosted a special webinar with Austrade, for US and Canadian medical device companies who may benefit from running clinical trials in Australia. The session explored ‘Australia as a medical device trial destination: Maintain momentum in your clinical development program’, and focused on first-in-human / early phase cardiovascular medical device trials. Discussions cover the clinical trials landscape in Australia and the impact of COVID-19 on maintaining research momentum, the opportunities for international collaboration and a German company’s firsthand experience as a multinational medical device company running clinical trial programs in Australia.

A special thanks to our stellar panel:

  • Hon. Peter McGauran – Australia’s Consul General and Senior Trade & Investment Commissioner, Austrade Houston
  • Dr Dan Grant – Managing Director & CEO, MTPConnect
  • Prof John Kovacic – Executive Director, Victor Chang Cardiac Research Institute
  • Prof Gemma Figtree – President, Australian Cardiovascular Alliance
  • Mr Falko Thiele – Director Clinical & Regulatory Affairs, BIOTRONIK Australia (HQ Germany)


Are You Exploring Pathways To Commercialise a Health Innovation Webinar

  • 30 June 2020

Hear from Boston-based CIMIT Chief Operating Officer Dr John Collins, Health Horizon Co-Founder & CEO Marcus Dawe and OncoRes Medical MD & CEO Dr Kath Giles to discuss how to best to navigate the pathways to commercialising health innovations. The team guided by our Senior Director Stakeholder Engagement Dr Rebecca Tunstall as MC, along with MTPConnect’s MD & CEO Dr Dan Grant, heard about the journey of OncoRes Medical developing introperative imaging technology to improve accuracy of breast cancer surgery. CIMIT’s GAITS model was showcased as a tool to help innovators map their commercialisation process to get their solutions to patients faster. And one of Australia’s latest health innovations, the Health Horizon platform, revealed how it keeps track of health innovations around the world for innovators, funders and the public so everyone can follow the progress of medical breakthroughs.